Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-04T21:39:10.561Z Has data issue: false hasContentIssue false

Nortriptyline Plasma Levels and Subjective Side Effects*

Published online by Cambridge University Press:  29 January 2018

Vincent E. Ziegler
Affiliation:
Department of Psychiatry, Washington University School of Medicine, 4940 Audubon Avenue, St Louis, Missouri 63110, USA
John R. Taylor
Affiliation:
Department of Psychiatry, Washington University School of Medicine, 4940 Audubon Avenue, St Louis, Missouri 63110, USA
Richard D. Wetzel
Affiliation:
Department of Psychiatry, Washington University School of Medicine, 4940 Audubon Avenue, St Louis, Missouri 63110, USA
John T. Biggs
Affiliation:
Department of Psychiatry, Washington University School of Medicine, 4940 Audubon Avenue, St Louis, Missouri 63110, USA

Abstract

Nortriptyline plasma levels and the incidence and severity of the common subjective side effects of the tricyclic antidepressants were determined in 26 patients during six weeks of treatment with nortriptyline. The total corrected (treatment minus pre-treatment) score of the eight side effects most independent of the severity of depression correlated (0 · 60) with the nortriptyline plasma level. Increased perspiration (o · 59) and dry mouth (o · 54) were the individual corrected side effects which most consistently correlated with the plasma level. These subjective side effects may serve as clinically useful guides to dosage adjustments during treatment, though their value is limited by the magnitude of the correlations and the need to correct for their presence prior to treatment.

Type
Papers
Copyright
Copyright © Royal College of Psychiatrists, 1978 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

Supported in part by United States Public Health Service Grants MH-25571, RR-00954 and DA-00259.

References

Åsberg, M., Crönholm, B., Sjöqvist, F. & Tuck, D. (1970) Correlation of subjective side effects with plasma concentrations of nortriptyline. British Medical Journal, iv, 1821.Google Scholar
Åsberg, M., Crönholm, B., Sjöqvist, F. & Tuck, D. (1971) Relationship between plasma level and therapeutic effect of nortriptyline. British Medical Journal, iii, 331–4.Google Scholar
Åsberg, M. & Germanis, M. (1972) Ophthalmological effects of nortriptyline: relationship to plasma level. Pharmacology, 7, 349–56.Google Scholar
Biggs, J. T., Holland, W. H., Chang, S. S., Hipps, P. P. & Sherman, W. R. (1976) The electron beam ionization mass fragmentographic analysis of tricyclic antidepressants in human plasma. Journal of Pharmaceutical Sciences, 65, 261–8.CrossRefGoogle ScholarPubMed
Braithwaite, R. A., Goulding, R., Theano, G., Bailey, J. & Coppen, A. (1972) Plasma concentration of amitriptyline and clinical response. Lancet, i, 12971300.Google Scholar
Burrows, G. D., Davies, B. & Scoggins, B. A. (1972) Plasma concentration of nortriptyline and clinical response in depressive illness. Lancet, ii, 619–23.Google Scholar
Burrows, G. D., Scoggins, B. A., Turecer, L. R. & Davies, B. (1974) Plasma nortriptyline and clinical response. Clinical Pharmacology and Therapeutics, 16, 639–44.CrossRefGoogle ScholarPubMed
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A. Jr, Winokur, G. & Muñoz, R. (1972) Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 5763.Google Scholar
Freyschuss, U., Sjöqvist, F. & Tuck, D. (1970) Tyramine pressor effects in man before and during treatment with nortriptyline or ECT: Correlation between plasma level and effect of nortriptyline. Pharmacologia Clinica, 2, 72–8.Google Scholar
Gram, L. F., Reisby, N., Ibsen, I., Nagy, A., Dencker, S. J., Bech, P., Petersen, G. O. & Christiansen, J. (1976) Plasma levels and anti-depressive effect of imipramine. Clinical Pharmacology and Therapeutics, 19, 318–24.Google Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 5662.Google Scholar
Hammer, W., Idelström, C. M. & Sjöqvist, F. (1967) Chemical control of antidepressant drug therapy. In Proceedings of the First International Symposium on Antidepressant Drugs (eds Garattini, S. and Dukes, M. N. G.), pp 301–10. Amsterdam: Excerpta Medica Series 122 Google Scholar
Kragh-Sørensen, P., Åsberg, M. & Eggert-Hansen, C. (1973) Plasma nortriptyline levels in endogenous depression. Lancet, i, 113–15.Google Scholar
Kragh-Sørensen, P., Eggert-Hansen, C., Baastrup, P. C. & Hvidberg, E. F. (1976) Self-inhibiting action of nortriptyline's antidepressive effect at high plasma levels. Psychopharmacologia (Berlin), 45, 305–12.CrossRefGoogle ScholarPubMed
Petit, J. M., Spiker, D. G., Ruwitch, J. F., Ziegler, V. E., Weiss, A. M. & Biggs, J. T. (1977) Tricyclic antidepressant plasma levels and adverse effects in 40 overdose cases. Clinical Pharmacology and Therapeutics, 21, 4751.Google Scholar
Siegel, S. (1956) Non-Parametric Statistics for the Behavioral Sciences. New York: McGraw-Hill Book Co, Inc.Google Scholar
Whyte, S. F., MacDonald, A. J., Naylor, G. J. & Moody, J. P. (1976) Plasma concentrations of protriptyline and clinical effects in depressed women. British Journal of Psychiatry, 128, 384–90.Google Scholar
Ziegler, V. E., Clayton, P. J., Taylor, J. R., Co, B. T. & Biggs, J. T. (1976a) Nortriptyline plasma levels and therapeutic response. Clinical Pharmacology and Therapeutics, 20, 458–63.Google Scholar
Ziegler, V. E., Co, B. T., Taylor, J. R., Clayton, P. J. & Biggs, J. T. (1976b) Amitriptyline plasma levels and therapeutic response. Clinical Pharmacology and Therapeutics, 19, 795801.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.